Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisei Okamoto

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Contemporary Brachytherapy|May 24, 2021
Prostate cancer with nodular bladder invasion (stage T4N1) cured by low-dose-rate brachytherapy with seminal vesicle implantation in combination with external beam radiotherapy of biologically effective dose ≥ 220 Gy: a case reportKeisei Okamoto
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2012
Epigenetics: a way to understand the origin and biology of testicular germ cell tumorsKeisei Okamoto
Translational Andrology and Urology|May 9, 2024
What is the key factor determining effectiveness of radiotherapy for high-risk prostate cancer: a hidden message from RTOG 0521Keisei Okamoto
Journal of Contemporary Brachytherapy|December 8, 2022
Very high-risk locally advanced prostate ductal adenocarcinoma cured using low-dose-rate brachytherapy, with seminal vesicle implantation in combination with external beam radiotherapy at a biologically effective dose ≥ 220 Gy: two case reports with a long-term follow-upKeisei Okamoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Application and limitation of low-dose rate (LDR) brachytherapy for prostate cancer]Keisei Okamoto
Journal of Applied Clinical Medical Physics|May 3, 2021
Ten-step method of high-dose LDR <sup>125</sup> I brachytherapy for intermediate-risk prostate cancerKeisei Okamoto
International Journal of Andrology|May 25, 2007
Epigenetic profile of testicular germ cell tumoursKeisei Okamoto, Takahiro Kawakami
Journal of Contemporary Brachytherapy|March 28, 2017
High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancerKeisei Okamoto, Akinori Wada, Naoaki Kohno
Genes, Chromosomes & Cancer|January 27, 2005
Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumorsCheng Zhang, Takahiro Kawakami, Yusaku Okada, et al.
Lancet (London, England)|January 16, 2004
XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancerTakahiro Kawakami, Keisei Okamoto, Osamu Ogawa, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Contemporary Brachytherapy|May 24, 2021
Prostate cancer with nodular bladder invasion (stage T4N1) cured by low-dose-rate brachytherapy with seminal vesicle implantation in combination with external beam radiotherapy of biologically effective dose ≥ 220 Gy: a case reportKeisei Okamoto
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2012
Epigenetics: a way to understand the origin and biology of testicular germ cell tumorsKeisei Okamoto
Translational Andrology and Urology|May 9, 2024
What is the key factor determining effectiveness of radiotherapy for high-risk prostate cancer: a hidden message from RTOG 0521Keisei Okamoto
Journal of Contemporary Brachytherapy|December 8, 2022
Very high-risk locally advanced prostate ductal adenocarcinoma cured using low-dose-rate brachytherapy, with seminal vesicle implantation in combination with external beam radiotherapy at a biologically effective dose ≥ 220 Gy: two case reports with a long-term follow-upKeisei Okamoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Application and limitation of low-dose rate (LDR) brachytherapy for prostate cancer]Keisei Okamoto
Journal of Applied Clinical Medical Physics|May 3, 2021
Ten-step method of high-dose LDR <sup>125</sup> I brachytherapy for intermediate-risk prostate cancerKeisei Okamoto
International Journal of Andrology|May 25, 2007
Epigenetic profile of testicular germ cell tumoursKeisei Okamoto, Takahiro Kawakami
Journal of Contemporary Brachytherapy|March 28, 2017
High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancerKeisei Okamoto, Akinori Wada, Naoaki Kohno
Genes, Chromosomes & Cancer|January 27, 2005
Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumorsCheng Zhang, Takahiro Kawakami, Yusaku Okada, et al.
Lancet (London, England)|January 16, 2004
XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancerTakahiro Kawakami, Keisei Okamoto, Osamu Ogawa, et al.
Pageof 4